Cell migration inducing hyaluronidase 1 promotes growth and metastasis of papillary thyroid carcinoma

ABSTRACT Cell migration inducing hyaluronidase 1 (CEMIP) mediates catabolism of hyaluronan, and participates in the cell metastasis, invasion, and motility. Dysregulated CEMIP expression was associated with progression and prognosis of tumors. The role of CEMIP in papillary thyroid carcinoma (PTC) remains unknown. Our study showed that CEMIP was upregulated in both tissues and cells of PTC. Silencing of CEMIP reduced cell proliferation and suppressed migration and invasion of PTC. Protein expression of phosphorylated STAT3 (Signal Transducer And Activator Of Transcription 3) (p-STAT3), AKT (p-AKT) and p65 (p-p65) were decreased by CEMIP silencing in PTC cells. Pyruvate dehydrogenase kinase 4 (PDK4) over-expression attenuated CEMIP silencing-induced decrease in p-STAT3, p-AKT and p-p65. Silencing of CEMIP-induced decrease in cell proliferation and metastasis in PTC were restored by over-expression of STAT3. CEMIP functioned as an oncogenic gene in PTC through PDK4-mediated activation of STAT3/AKT/NF-κB pathway. Graphical abstract

[1]  C. Chao,et al.  circCCDC66 promotes thyroid cancer cell proliferation, migratory and invasive abilities and glycolysis through the miR-211-5p/PDK4 axis , 2021, Oncology letters.

[2]  K. Cheng,et al.  CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis , 2021, Experimental and therapeutic medicine.

[3]  G. Kroemer,et al.  PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis. , 2021, Cell reports.

[4]  Lihong Li,et al.  Cell migration inducing hyaluronidase 1 (CEMIP) activates STAT3 pathway to facilitate cell proliferation and migration in breast cancer , 2020, Journal of receptor and signal transduction research.

[5]  N. Mao,et al.  A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis , 2020, Journal of Cancer Research and Clinical Oncology.

[6]  M. K. Siu,et al.  Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer , 2020, British Journal of Cancer.

[7]  Xubao Liu,et al.  Unusual metastasis of papillary thyroid cancer to the pancreas, liver, and diaphragm: a case report with review of literature , 2020, BMC Surgery.

[8]  David R. Jones,et al.  Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis , 2019, Nature Cell Biology.

[9]  M. Hedayati,et al.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review , 2019, Endocrine.

[10]  S. Yin,et al.  A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3 , 2019, Cell Death & Disease.

[11]  Z. Zong,et al.  CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Yidi Guo,et al.  IL-8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF-κB pathway in prostate cancer , 2019, Molecular medicine reports.

[13]  Maheedhara R. Guda,et al.  Targeting PDK4 inhibits breast cancer metabolism. , 2018, American journal of cancer research.

[14]  J. Marine,et al.  The Endosomal Protein CEMIP Links WNT Signaling to MEK1-ERK1/2 Activation in Selumetinib-Resistant Intestinal Organoids. , 2018, Cancer research.

[15]  Xiaohui Sun,et al.  Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China , 2018, BMC Cancer.

[16]  Yarong Song,et al.  AMPK/GSK3β/β‐catenin cascade‐triggered overexpression of CEMIP promotes migration and invasion in anoikis‐resistant prostate cancer cells by enhancing metabolic reprogramming , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  H. Y. Kim,et al.  Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer , 2018, Scientific Reports.

[18]  Yidi Guo,et al.  IL‑8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF‑κB pathway in prostate cancer. , 2017, Molecular medicine reports.

[19]  D. Kallogjeri,et al.  Development of a New Clinical Severity Staging System for Patients With Nonmetastatic Papillary Thyroid Carcinoma , 2017, JAMA otolaryngology-- head & neck surgery.

[20]  Y. Li,et al.  Central Role of CEMIP in Tumorigenesis and Its Potential as Therapeutic Target , 2017, Journal of Cancer.

[21]  Qiong Shen,et al.  Down‐regulation of KIAA1199/CEMIP by miR‐216a suppresses tumor invasion and metastasis in colorectal cancer , 2017, International journal of cancer.

[22]  J. Ji,et al.  KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer , 2017, PLoS ONE.

[23]  Jill S Barnholtz-Sloan,et al.  Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival , 2015, Oncotarget.

[24]  N. Sosonkina,et al.  The Role of STAT3 in Thyroid Cancer , 2014, Cancers.

[25]  S. Janz,et al.  NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma , 2010, Molecular Cancer.

[26]  L. Niskanen,et al.  Hyaluronan expression in differentiated thyroid carcinoma , 2002, The Journal of pathology.

[27]  X. Fang,et al.  Silencing of CEMIP suppresses Wnt/β-catenin/Snail signaling transduction and inhibits EMT program of colorectal cancer cells. , 2018, Acta histochemica.

[28]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.